Senior citizens and other Medicare enrollees can now get a break on the cost of their insulin. They won’t pay more than $35 a month for each insulin prescription that’s covered by their ...

Starting next month, some Medicare beneficiaries will pay less out of pocket for 27 prescription drugs whose prices rose faster than inflation late last year, the Department of Health and Human ...

Tucked deep inside the 267-page 2025 Medicare Trustees report is a projection that the standard monthly Medicare Part B ...

IRA’s $2,000 out-of-pocket cap helps few; most won’t hit the threshold Insurers raise deductibles, replace flat co-pays with costlier coinsurance ...

The Inflation Reduction Act requires drugmakers to offer rebates to Medicare if they raise the price of medicines faster than inflation. Soaring prescription-drug prices are one reason that ...

According to a February 2022 analysis by the Kaiser Family Foundation, about half of all drugs covered by Medicare had price increases greater than the rate of inflation from 2019 to 2020.

The Inflation Reduction Act, which was signed into law on Aug. 16, 2022, is designed to help seniors and retirees pay for Medicare costs that have gone up in recent months due to inflation. One of ...

The 2022 Inflation Reduction Act helps minimize the rising U.S. healthcare costs, including Medicare premiums, deductibles, and drug prices. With inflation in the United States at a 40-year high ...

In addition to negotiated drug prices, the Inflation Reduction Act caps out-of-pocket prescription drug costs at $2,000, starting in 2025, for those with Medicare Part D drug plans.

The Democrats' Inflation Reduction Act would grant Medicare the authority to negotiate drug prices and cap out-of-pocket costs at $2,000 a year.

Starting next month, some Medicare beneficiaries will pay less out of pocket for 27 prescription drugs whose prices rose faster than inflation late last year, the Department of Health and Human ...

Bob Powell: The Inflation Reduction Act impacts Medicare beneficiaries and would-be beneficiaries. Here to talk with me about that is Jae Oh, author of maximize or Medicare.